NWANNE NKWOCHA: Open Payments
NPI 1972081438 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 42 payments from 10 companies in 2025. Trend: 2023 $387 · 2024 $756 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 7 | $157 |
| Amgen Inc. | 13 | $142 |
| GlaxoSmithKline, LLC. | 7 | $131 |
| Novo Nordisk Inc | 6 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $37 |
| Philips North America LLC | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: YUPELRI, TRELEGY ELLIPTA, OTEZLA, JARDIANCE, Ozempic, REPATHA, Extended Holter, FARXIGA.
Industry payments across FL — which companies pay providers there.
